间皮素作为癌症免疫治疗的生物标志物和治疗靶点
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer.
癌症仍是一个关键的全球健康问题,原因在于发现晚、耐药和高死亡率。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The Immune Microenvironment in Gastric Cancer: Prognostic Prediction.
The Immune Microenvironment in Gastric Cancer: Prognostic Prediction.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
尽管治疗方法已经发展,胃癌(GC)仍然导致高死亡率和发病率,是全球癌症相关死亡的第四大原因和第五大常见癌症。为了了解与GC预后预测相关的因素并发现有效的治疗靶点,以往关于肿瘤发病机制的研究主要集中在癌细胞本身;近年来,大量研究表明癌症侵袭和转移是癌细胞与微环境共同进化的结果。肿瘤微环境的研究似乎有助于预后预测并识别治疗GC的潜在靶点。在这篇综述中,我们主要介绍近年来GC预后预测和免疫微环境的研究进展,重点关注GC中的癌症相关成纤维细胞(CAFs)、肿瘤相关巨噬细胞(TAMs)和TIL(肿瘤浸润淋巴细胞)(TILs),并讨论GC新治疗靶点的可能性。
Although therapeutic methods have been developed, gastric cancer (GC) still leads to high rates of mortality and morbidity and is the fourth leading cause of cancer-associated death and the fifth most common cancer worldwide. To understand the factors associated with the prognostic prediction of GC and to discover efficient therapeutic targets, previous studies on tumour pathogenesis have mainly focused on the cancer cells themselves; in recent years, a large number of studies have shown that cancer invasion and metastasis are the results of coevolution between cancer cells and the microenvironment.
It seems that studies on the tumour microenvironment could help in prognostic prediction and identify potential targets for treating GC. In this review, we mainly introduce the research progress for prognostic prediction and the immune microenvironment in GC in recent years, focusing on cancer-associated fibroblasts (CAFs), tumour-associated macrophages (TAMs), and tumour-infiltrating lymphocytes (TILs) in GC, and discuss the possibility of new therapeutic targets for GC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。